242 results
Page 6 of 13
8-K
n888i0 rfjkvm2
26 Mar 20
TherapeuticsMD Provides COVID-19-Related Business Update
4:06pm
8-K
EX-99.1
6iwxqetaxpfva0b n8
24 Mar 20
Departure of Directors or Certain Officers
7:53am
8-K
EX-99.1
r18e4oud
3 Mar 20
Regulation FD Disclosure
7:00am
POS AM
fncr4wau8ptvf2yw
24 Feb 20
Prospectus update (post-effective amendment)
4:56pm
POSASR
lxws78c
24 Feb 20
Automatic shelf registration (post-effective amendment)
4:09pm
8-K
EX-99.2
vht0k o81i0
20 Feb 20
TherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial Results
6:57am
8-K
EX-99.1
58yuwqo4
20 Feb 20
TherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial Results
6:57am
8-K
EX-99.1
ynxclimgl6
14 Jan 20
Building the Premier Women’s Health Company JP Morgan Conference January 2020
6:55am
8-K
EX-99.1
f2vab7bqac3 1g
30 Dec 19
TherapeuticsMD Announces Amendment to
7:02am
8-K
EX-99.1
vpf0kbdcqmdi eiu
18 Dec 19
Regulation FD Disclosure
5:27pm
8-K
EX-99.1
9v1o6f
6 Nov 19
TherapeuticsMD Announces Third Quarter 2019 Financial Results
4:08pm
8-K
EX-99.2
q4vqtbe6ct3ai0ai
6 Nov 19
TherapeuticsMD Announces Third Quarter 2019 Financial Results
4:08pm
424B2
s4k6vcu
25 Oct 19
Prospectus for primary offering
4:47pm
FWP
fsjacjasaq48
24 Oct 19
Free writing prospectus
6:02am
8-K
EX-99.1
gxx cxhs7
23 Oct 19
TherapeuticsMD Announces Estimated Third Quarter 2019 Financial Results
5:25pm
FWP
wwxf8hi kyi
23 Oct 19
Free writing prospectus
5:16pm
424B5
d8cmrbi
23 Oct 19
Prospectus supplement for primary offering
5:15pm
8-K
EX-99.1
006xy813de
15 Oct 19
Regulation FD Disclosure
7:00am